Ownership history in COREPATH WEALTH PARTNERS LLC Β· 3 quarters on record
This page tracks every 13F SEC filing in which COREPATH WEALTH PARTNERS LLC reported a position in ISHARES TR (IWR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π COREPATH WEALTH PARTNERS LLC underperformed the S&P 500 by β10.7% annually on this IWR position. Average cost basis: $94.87. Maximum drawdown during holding period: β0.0%.
β Significantly underperformed the S&P 500 by 10.7% ann.
2 quarters analyzed
Best entry: $91.05 (2025 Q2) Β· Worst: $96.01 (2025 Q4)
π No drawdown exceeding 20% during the holding period β exceptionally stable.
3 adds Β· 0 trims. π Consistently bullish β fund kept accumulating this position.
π COREPATH WEALTH PARTNERS LLC has been actively increasing its IWR allocation β a bullish signal from insiders.
Currently 1.39% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size